Status:
SUSPENDED
3TC or No 3TC for HIV With 3TC Resistance
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
CIHR Canadian HIV Trials Network
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effects of continuing or discontinuing 3TC treatment in the presence of HIV virus with 3TC resistance for persons who are on a regimen including least three...
Eligibility Criteria
Inclusion
- Be HIV positive
- Be at least 18 years old.
- Currently receiving 3TC for HIV infection in conjunction with at least three other antiretroviral drugs. Must have started this regimen at least three months prior to starting this study.
- A plasma viral load of less than 50 copies/mL on at least two occasions (measured at least 28 days apart immediately prior to screening).
- Evidence of resistance to 3TC
Exclusion
- Pregnancy or breastfeeding.
- Hepatitis B surface antigen (HbsAg) positive at time of screening or with the previous year.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00143728
Start Date
January 1 2004
End Date
May 1 2010
Last Update
September 25 2008
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Downtown IDC
Vancouver, British Columbia, Canada
2
Cool Aid Community Health Centre
Victoria, British Columbia, Canada
3
St. Boniface General Hospital
Winnipeg, Manitoba, Canada
4
Haven Program
Greater Sudbury, Ontario, Canada